North America Sepsis Diagnostics Market Size & Outlook
North America sepsis diagnostics market, 2018-2030 (US$M)
Related Markets
North America sepsis diagnostics market highlights
- The North America sepsis diagnostics market generated a revenue of USD 444.5 million in 2022.
- The market is expected to grow at a CAGR of 7.1% from 2023 to 2030.
- In terms of segment, blood culture media was the largest revenue generating product in 2022.
- Assay Kits & Reagents is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, Canada is expected to register the highest CAGR from 2023 to 2030.
North America data book summary
| Market revenue in 2022 | USD 444.5 million |
| Market revenue in 2030 | USD 770.1 million |
| Growth rate | 7.1% (CAGR from 2022 to 2030) |
| Largest segment | Blood culture media |
| Fastest growing segment | Assay Kits & Reagents |
| Historical data covered | 2018 - 2021 |
| Base year for estimation | 2022 |
| Forecast period covered | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Blood Culture Media, Assay Kits & Reagents, Software |
| Key market players worldwide | BD, BioMerieux SA, Thermo Fisher Scientific Inc, Danaher Corp, Roche Holding AG ADR, Luminex, Koninklijke Philips NV, Bruker Corp, Cepheid, Immunexpress |
Other key industry trends
- In terms of revenue, North America region accounted for 44.4% of the global sepsis diagnostics market in 2022.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 431.0 million by 2030.
Blood culture media was the largest segment with a revenue share of 38.99% in 2022. Horizon Databook has segmented the North America sepsis diagnostics market based on instruments, blood culture media, assay kits & reagents, software covering the revenue growth of each sub-segment from 2018 to 2030.
North America held the largest share of 44.1% in 2023 and is expected to maintain this position over the forecast period. This can be attributed to the well-established healthcare infrastructure, which has led to an increase in the adoption of advanced sepsis diagnostic solutions in the region.
Furthermore, high incidence of sepsis is expected to fuel demand for novel sepsis diagnostic solutions. According to the data published by CDC in March 2024, one in three Americans who died in the hospital had sepsis during hospitalization.
This led to the high demand for rapid & accurate diagnosis and increased the adoption of point-of-care testing. Moreover, the rise in the geriatric population, increase in investments for research & development, and availability of favorable reimbursement policies are expected to drive the market.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Sepsis Diagnostics Market Scope
Sepsis Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America sepsis diagnostics market size, by country, 2018-2030 (US$M)
North America Sepsis Diagnostics Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
